Sign in
Taking people in United StatesPhase 1/2

Cannabidiol as extra pain relief after shoulder surgery

Tests Epidiolex against a placebo for pain after shoulder surgery in adults.

Key facts

Who runs it
The Methodist Hospital Research Institute
Where
Houston, United StatesSee the site
Trial code
Registry title
CBD for Pain Following Orthopedic Shoulder Surgery
Status
Recruiting
Phase
Phase 1/2
People taking part
80 people, planned
Started
24 May 2024
Expected to end
30 Dec 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Epidiolex
  • Placebo oral solution
Record updated
16 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults having rotator cuff repair surgery on the shoulder. It tests whether Epidiolex (cannabidiol) lowers pain after surgery, compared with a placebo.

Age
Above the age of 18 years old
Sex
All sexes can join.
Disease stage
People undergoing rotator cuff repair surgery with standard anesthesia.
Earlier treatment
People who had a revision shoulder arthroplasty (repeat shoulder replacement), regular marijuana/cannabidiol use (not on the skin) in the past 6 months, or care by a pain management specialist cannot join.
Biomarker or test result
Women must have a negative urine pregnancy test before surgery.

Main reasons for not taking part

  • Liver disease or liver problems
  • Currently taking narcotics, valproate, clobazam, CNS depressants or certain drugs that affect the liver
  • History of substance or alcohol abuse
  • Pregnancy or breastfeeding
  • Diagnosed psychiatric disorder, untreated sleep disorder, or allergy to cannabidiol or sesame seeds

The registry criteria, word for word

Show all 24 criteriaShow less

Who can take part

  • Above the age of 18 years old
  • Undergoing a rotator cuff repair surgery
  • Receiving standard anesthesia during surgery
  • If a subject is of reproductive potential, they must be on effective contraception one month prior, during treatment, and one month following treatment

Who cannot take part

  • Are currently taking valproate or clobazam
  • Are currently taking a moderate/strong CYP3A4 or CYP2C19 inhibitor
  • Are currently taking a strong CYP3A4 or CYP2C19 inducer
  • Are currently taking narcotics
  • Those currently or previously under the care of a pain management specialist
  • Pregnancy (As part of standard of care, all female participants will be administered a urine pregnancy test prior to surgery. A negative test result is required to participate in the study.)
  • If you are taking any medications with known risks for suicidal behavior and ideation
  • Patients currently taking central nervous system (CNS) depressants
  • Patients currently taking other drugs with known hepatotoxicity
  • Vulnerable populations; Patients taking concomitant medications which are substrate of uridine 5'-diphospho-glucuronosyltransferase 1-9 (UGT1A9), uridine diphosphate-glucuronosyltransferase 2B7 (UGT2B7), CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, and P-gp will be monitored for potential adverse events based on the Epidiolex® label for the concomitant medication being used
  • History of revision shoulder arthroplasty
  • History of liver disease or impairment
  • History of substance/alcohol abuse
  • History of marijuana/cannabidiol (not including topical) regular use within the past 6 months
  • Allergy related to cannabidiol
  • Allergy related to sesame seeds
  • If you have a diagnosed psychiatric disorder
  • If you are untreated for a diagnosed sleeping disorder
  • Under the age of 18 years old
  • If you are actively breastfeeding

Where in United States

  • Houston Methodist HospitalHouston, United StatesContact: Haley M Goble, MHA, CRCCTaking people

About the trial

What the trial wants to find out

The goal of the study is to learn if Epidiolex (cannabidiol) works as a additional pain medication in patients who have had orthopedic shoulder surgery. It is also to learn about safe dosages and identify any side effects after surgery.

Read full original descriptionShow less

Researchers will compare Epidiolex to a placebo solution to see if Epidiolex lowers pain after shoulder surgery.

Participants will:

* track their pain and what medications they use every day in a provided pain diary. A researchers will call every seven days to check on the participant and diary. * Complete two short surveys. Once before surgery and once after. * Have bloodwork tested after surgery

The 2 groups in the trial

  • Epidiolex (cannabidiol)Treatment being tested

    Patients randomized to the Epidiolex group will take 150mg of Epidiolex with food twice daily for 14 days beginning the day of surgery.

    Treatment: Epidiolex

  • PlaceboPlacebo, for comparison

    Patients randomized to the placebo group will take 150mg of oral placebo solution with food for 14 days beginning the day of surgery.

    Treatment: Placebo oral solution

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Cannabidiol (CBD) As A Pain Adjunct in Orthopedic Surgical Patients: A Randomized Control Trial
Plain-language title
Cannabidiol as extra pain relief after shoulder surgeryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
16 April 2026